Bristol-Myers Squibb Co (NYSE:BMY)
| 61.76 BATS BZX Real-Time Price As of 3:32pm ET |  +0.43 / +0.70%Today’s Change | 45.76 Today|||52-Week Range 67.16 | -0.44% Year-to-Date |
Latest BMY News | Press Releases
| 3 Top Stocks That'll Make You Richer in March (and Beyond) 5:51am / MotleyFool.com - Paid Partner Content | Nektar (NKTR) Q4 Earnings and Revenues Top, Pipeline On Track Feb 26 / Zacks.com - Paid Partner Content |
| Retail, Tech Earnings, and Berkshire's Surprising Buys Feb 27 / MotleyFool.com - Paid Partner Content | FATE Reports Wider-Than-Expected Q4 Loss on Higher Expenses Feb 25 / Zacks.com - Paid Partner Content |
| Buy This Blue Chip on the Dip Feb 26 / MotleyFool.com - Paid Partner Content | bluebird (BLUE) Q4 Loss Narrower than Expected, Sales Miss Feb 24 / Zacks.com - Paid Partner Content |
| Iovance (IOVA) Q4 Earnings Miss Estimates, Pipeline in Focus Feb 26 / Zacks.com - Paid Partner Content | Epizyme's (EPZM) Q4 Loss Wider than Expected, Sales Beat Feb 24 / Zacks.com - Paid Partner Content |
| Agios' (AGIO) Q4 Loss In Line, Revenues Surpass Estimates Feb 26 / Zacks.com - Paid Partner Content | Here's Why Bristol Myers Squibb Is Making A Mistake With Its Cash Feb 24 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 61.33 |
| Today’s open | 61.76 |
| Day’s range | 61.58 - 62.06 |
| Volume | 4,875,486 |
| Average volume (3 months) | 11,446,213 |
| Market cap | $137.4B |
Data as of 3:32pm ET, 03/01/2021
Growth & Valuation
| Earnings growth (last year) | -297.94% |
| Earnings growth (this year) | +16.15% |
| Earnings growth (next 5 years) | +6.76% |
| Revenue growth (last year) | +62.62% |
| P/E ratio | NM |
| Price/Sales | 3.29 |
| Price/Book | 3.64 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NVONovo Nordisk | +1.75 | +2.46% |
| AZNAstraZeneca | -0.09 | -0.19% |
| SNYSanofi | -0.02 | -0.04% |
| MRKMerck | +0.02 | +0.03% |
Data as of 3:32pm ET, 03/01/2021
Financials
| Next reporting date | April 29, 2021 |
| EPS forecast (this quarter) | $1.81 |
| Annual revenue (last year) | $42.5B |
| Annual profit (last year) | -$9.0B |
| Net profit margin | -21.20% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
